VIBERZI

This brand name is authorized in Canada, New Zealand, United States

Active ingredients

The drug VIBERZI contains one active pharmaceutical ingredient (API):

1 Eluxadoline
UNII 45TPJ4MBQ1 - ELUXADOLINE

Eluxadoline is a locally acting, mixed mu opioid receptor (μOR) agonist and delta opioid receptor (δOR) antagonist. Eluxadoline is also an agonist at the kappa opioid receptor (κOR). Eluxadoline has demonstrated efficacy in normalizing GI transit and defecation in several models of stress induced or post GI inflammation-altered GI function in animals.

Read about Eluxadoline

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
VIBERZI Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A07DA06 A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02460890, 02460904
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 18681, 18682
Country: US FDA, National Drug Code Identifier(s): 61874-075, 61874-100

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.